IRIS UniCatt

Sgalla, Giacomo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.025
AS - Asia 1.822
EU - Europa 1.198
SA - Sud America 423
AF - Africa 61
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 1
Totale 5.534
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.952
SG - Singapore 805
CN - Cina 361
BR - Brasile 359
IT - Italia 330
VN - Vietnam 215
SE - Svezia 213
DE - Germania 132
FR - Francia 125
BD - Bangladesh 116
GB - Regno Unito 74
IE - Irlanda 67
PL - Polonia 62
ID - Indonesia 52
HK - Hong Kong 51
RU - Federazione Russa 50
JP - Giappone 47
IN - India 43
CA - Canada 31
FI - Finlandia 29
KR - Corea 29
MX - Messico 27
AR - Argentina 23
AT - Austria 22
IQ - Iraq 16
UA - Ucraina 15
ZA - Sudafrica 15
BE - Belgio 13
NL - Olanda 13
ES - Italia 12
MA - Marocco 12
SA - Arabia Saudita 12
TR - Turchia 12
IR - Iran 11
EC - Ecuador 10
PK - Pakistan 9
VE - Venezuela 9
AE - Emirati Arabi Uniti 8
CH - Svizzera 8
EG - Egitto 8
PY - Paraguay 8
LT - Lituania 7
UZ - Uzbekistan 7
CO - Colombia 6
KE - Kenya 6
TN - Tunisia 6
CI - Costa d'Avorio 5
PH - Filippine 5
RO - Romania 5
CR - Costa Rica 4
CZ - Repubblica Ceca 4
TW - Taiwan 4
AL - Albania 3
AU - Australia 3
AZ - Azerbaigian 3
DZ - Algeria 3
ET - Etiopia 3
SK - Slovacchia (Repubblica Slovacca) 3
TT - Trinidad e Tobago 3
UY - Uruguay 3
BO - Bolivia 2
HN - Honduras 2
IL - Israele 2
JO - Giordania 2
LV - Lettonia 2
OM - Oman 2
PE - Perù 2
AO - Angola 1
BB - Barbados 1
BG - Bulgaria 1
BY - Bielorussia 1
CG - Congo 1
DM - Dominica 1
DO - Repubblica Dominicana 1
EU - Europa 1
GE - Georgia 1
GR - Grecia 1
GT - Guatemala 1
GY - Guiana 1
HR - Croazia 1
HU - Ungheria 1
JM - Giamaica 1
KZ - Kazakistan 1
LB - Libano 1
LK - Sri Lanka 1
MD - Moldavia 1
MK - Macedonia 1
MM - Myanmar 1
MN - Mongolia 1
MY - Malesia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PR - Porto Rico 1
PS - Palestinian Territory 1
PT - Portogallo 1
QA - Qatar 1
RS - Serbia 1
TZ - Tanzania 1
Totale 5.534
Salva come PNG Salva come JPEG
Città #
Singapore 448
San Jose 258
Chandler 208
Ashburn 202
Beijing 98
Rome 89
The Dalles 84
Ho Chi Minh City 73
Dublin 67
Milan 66
New York 60
Lauterbourg 53
Warsaw 52
Hefei 50
Los Angeles 50
Hong Kong 46
Jakarta 46
Tokyo 46
Hanoi 45
Frankfurt am Main 37
San Mateo 32
St Louis 31
São Paulo 31
Boston 29
Princeton 29
Fairfield 28
Moscow 26
Munich 24
Orem 23
Ann Arbor 22
Houston 22
Nuremberg 21
Santa Clara 21
Wilmington 20
North Bergen 19
Chicago 18
Dallas 18
Seoul 18
Council Bluffs 17
Helsinki 17
Kent 17
London 16
Woodbridge 16
Mexico City 15
Düsseldorf 14
Tukwila 14
Atlanta 13
Stockholm 13
Boardman 12
Buffalo 12
Rio de Janeiro 12
Vienna 12
Brooklyn 11
Shanghai 11
Brussels 10
Chennai 10
Denver 10
Bremen 9
Da Nang 9
Jacksonville 9
Kish 9
Naples 9
Paris 9
Poplar 9
Portsmouth 9
Pune 9
Amsterdam 8
Augusta 8
Belo Horizonte 8
Brasília 8
Casablanca 8
Curitiba 8
Montreal 8
Phoenix 8
Toronto 8
Catania 7
Florence 7
Guangzhou 7
Haiphong 7
Johannesburg 7
Las Vegas 7
Marseille 7
Turku 7
Washington 7
Ankara 6
Baghdad 6
Fortaleza 6
Guarulhos 6
Guayaquil 6
Hải Dương 6
Tashkent 6
Abidjan 5
Asunción 5
Buenos Aires 5
Cambridge 5
Caxias do Sul 5
Charlotte 5
Dubai 5
Falkenstein 5
Goiânia 5
Totale 3.065
Salva come PNG Salva come JPEG
Nome #
Residual respiratory impairment after COVID-19 pneumonia 196
Residual respiratory impairment after COVID-19 pneumonia 177
The management of Familial Pulmonary Fibrosis in different medical settings: Where does that leave us? An Italian nationwide survey 158
Mediastinal lymph node enlargement in idiopathic pulmonary fibrosis: Relationships with disease progression and pulmonary function trends 149
Usual Interstitial Pneumonia Pattern and Mycobacteria Lung Diseases: A Case Series 148
Experimental autotaxin inhibitors for the treatment of idiopathic pulmonary fibrosis 144
Case of a 33-Year-Old Woman With Hemoptysis and Migrant Nodular Cavitary Lesions 139
Disease progression across the spectrum of idiopathic pulmonary fibrosis: A multicentre study 135
Telemedicine-enabled, Hotel-based Management of Patients with COVID-19: A Single-Center Feasibility Study 134
Promising advances in treatments for the management of idiopathic pulmonary fibrosis 130
Digital lung auscultation: Will early diagnosis of fibrotic interstitial lung disease become a reality? 128
Antibody-based therapies for idiopathic pulmonary fibrosis 122
Acute Respiratory Distress Syndrome and Lung Fibrosis Complicating Surgery in a Patient with Crohn's Disease 122
A randomized trial of pamrevlumab in patients with COVID-19 pneumonia 120
Impact of chest imaging quality on the diagnosis of the usual interstitial pneumonia pattern: a hub and spoke study 120
BI 1015550: an investigational phosphodiesterase 4B (PDE4B) inhibitor for lung function decline in idiopathic pulmonary fibrosis (IPF) 119
Challenges in the diagnosis of idiopathic pulmonary fibrosis: the importance of a multidisciplinary approach 118
Antibody-based therapies for idiopathic pulmonary fibrosis 118
Reliability of crackles in fibrotic interstitial lung disease: a prospective, longitudinal study 115
COVID-19 Vaccine in Patients with Exacerbation of Idiopathic Pulmonary Fibrosis 113
Progressive Fibrosing Interstitial Lung Disease A Proposed Integrated Algorithm for Management 112
Home spirometry to assess efficacy of pirfenidone in progressive unclassifiable interstitial lung disease: better the devil you know than the devil you don't 111
Advances with pharmacotherapy for the treatment of interstitial lung disease 108
Existing and emerging biomarkers for disease progression in idiopathic pulmonary fibrosis 106
Multidisciplinary Evaluation of Interstitial Lung Diseases: New Opportunities Linked to Rheumatologist Involvement 106
Effectiveness of Nintedanib in Progressive Pulmonary Fibrosis Assessed by Progression Criteria: An Italian, Observational, Multicenter Study 102
Fibrotic Hypersensitivity Pneumonitis: Diagnosis and Management 100
Early diagnosis of idiopathic pulmonary fibrosis: Closer to the goal? 99
An update on emerging drugs for the treatment of idiopathic pulmonary fibrosis: a look towards 2023 and beyond 99
Role of Stenotrophomonas maltophilia isolation in patients with non CF bronchiectasis 96
An updated safety review of the drug treatments for idiopathic pulmonary fibrosis 94
Emerging drugs for the treatment of idiopathic pulmonary fibrosis: 2020 phase II clinical trials 94
Restless legs syndrome: A new comorbidity in idiopathic pulmonary fibrosis 93
Automated system for diagnosing pulmonary fibrosis using crackle analysis in recorded lung sounds based on iterative envelope mean fractal dimension filter 92
Monitoring small airway dysfunction in connective tissue disease-related interstitial lung disease: a retrospective and prospective study 91
Pamrevlumab for the treatment of idiopathic pulmonary fibrosis 91
Perception of the role of Telemedicine in Interstitial Lung Diseases: ­Findings from Società Italiana di Pneumologia/ Italian Respiratory ­Society (SIP-IRS) survey 90
A Simple Ratio in a Complex Disease: Exploring the Neutrophil-to-Lymphocyte Ratio in Idiopathic Pulmonary Fibrosis 90
Phase three clinical trials in idiopathic pulmonary fibrosis 86
Reply to: Huang and Wei, Kang et al., and Ehteshami-Afshar and Raj 83
An up-to-date review of approved and emerging antibody therapies for idiopathic pulmonary fibrosis 79
X-ray Micro-Computed Tomography for Nondestructive Three-Dimensional (3D) X-ray Histology 73
The Shorter, the Better: Can We Improve Efficiency of Idiopathic Pulmonary Fibrosis Trials? 72
Quantitative analysis of lung sounds for monitoring idiopathic pulmonary fibrosis: a prospective pilot study 71
“Velcro-type” crackles predict specific radiologic features of fibrotic interstitial lung disease 69
Do randomized clinical trials always provide certain results? 69
Mindfulness-based stress reduction in patients with interstitial lung diseases: a pilot, single-centre observational study on safety and efficacy 68
Better be an Agnostic than a Believer (at Least in Pulmonary Fibrosis) 66
Update in pulmonary fibrosis 2018 61
DEEP-LEARNING ANALYSIS OF HRCT IMAGES PREDICTS PULMONARY PROGRESSION AND MORTALITY IN SYSTEMIC SCLEROSIS RELATED INTERSTITIAL LUNG DISEASE 60
COVID-related fibrosis: insights into potential drug targets 58
Pharmacological treatment of idiopathic pulmonary fibrosis: Time to step out of the comfort zone? 53
DEEP-LEARNING ANALYSIS OF HRCT IMAGES PREDICTS PULMONARY PROGRESSION AND MORTALITY IN SYSTEMIC SCLEROSIS RELATED INTERSTITIAL LUNG DISEASE 52
Three-dimensional characterization of fibroblast foci in idiopathic pulmonary fibrosis 47
Long-term treatment with nintedanib and pirfenidone in idiopathic pulmonary fibrosis: a comparative, real-world cohort study 42
Impact of Chest CT Quality on the Diagnosis of Usual Interstitial Pneumonia (UIP) Pattern: A Hub and Spoke Study 26
null 19
Totale 5.633
Salva come PNG Salva come JPEG
Categoria #
all - tutte 24.779
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.779
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022268 21 9 4 27 9 11 2 55 15 8 57 50
2022/2023558 60 69 41 87 48 54 18 42 77 34 18 10
2023/2024389 13 82 13 23 16 31 25 14 19 45 55 53
2024/20251.044 36 12 92 54 84 35 53 49 126 121 238 144
2025/20263.156 369 185 184 395 519 134 482 137 170 228 184 169
2026/202720 20 0 0 0 0 0 0 0 0 0 0 0
Totale 5.633